CSJA:FRA
CSL ADR
30,60 €
arrow_upward
+0,66%(+0,20) 1 d.
12. nov., 22:00:00 GMT+1 · EUR
search
Visi simboli
| Simbols | Cena | Izmaiņas | % izmaiņu |
|---|
insights_autoNotiek galveno ieskatu ģenerēšana par šādu tēmu: CSJA…
Atvērt
29,80 €
Augsta
30,60 €
Zema
29,80 €
Tirgus kapitalizācija
97,03 mljrd.
Vid. apjoms
0,00
Apjoms
0,00
Augstākā 52 ned.
43,40 €
Zemākā 52 ned.
12,70 €
Darbinieku skaits
29 tūkst.
Atvērt
29,80 €
Augsta
30,60 €
Zema
29,80 €
Tirgus kapitalizācija
97,03 mljrd.
Vid. apjoms
0,00
Apjoms
0,00
Augstākā 52 ned.
43,40 €
Zemākā 52 ned.
12,70 €
Darbinieku skaits
29 tūkst.
Ziņas un raksti
No tīmekļa avotiem un ziņu partneriem
Kalkine
·
pirms 3 stundām
CSL Limited Buys Back 35,318 Shares on 12 November 2026 in On-Market Program
TheBull.com.au
·
pirms 8 stundām
CSL Shares At 52Wk Highs: Can The Rally Stretch To Sixth Months?
Kalkine
·
pirms 2 dienām
CSL Limited Buys Back 44,235 Shares on 10 November 2026 Under $1.15 Billion Program
Kalkine
·
pirms 3 dienām
CSL Limited Buys Back 47,255 Shares on 9 November 2026 Under $1.15 Billion Program
Profils
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications. The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994. Wikipedia
Par “CSL ADR”
ĢenerāldirektorsPaul McKenzie
Darbinieki29 tūkst.
Dibināšanas datums1916
Galvenais birojsMelburna, Viktorija, Austrālija
SektorsHealth Care
Nozare-
Tīmekļa vietnecsl.com